Literature DB >> 23041602

Cancer vaccines and T cell therapy.

Katayoun Rezvani1, Joshua D Brody, Holbrook E Kohrt, Aaron C Logan, Ranjana Advani, Debra Katherine Czerwinski, Wen-Kai Weng, Robert S Negrin, Victoria Carlton, Malek Faham, Ronald Levy, John Barrett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23041602      PMCID： PMC4313548          DOI： 10.1016/j.bbmt.2012.09.020

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  26 in total

Review 1.  Selective depletion strategies in allogeneic stem cell transplantation.

Authors:  S Mielke; S R Solomon; A J Barrett
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

2.  Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.

Authors:  S A Rosenberg; J C Yang; D J Schwartzentruber; P Hwu; F M Marincola; S L Topalian; N P Restifo; M E Dudley; S L Schwarz; P J Spiess; J R Wunderlich; M R Parkhurst; Y Kawakami; C A Seipp; J H Einhorn; D E White
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

3.  Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.

Authors:  Ulrike Gerdemann; Usha Katari; Anne S Christin; Conrad R Cruz; Tamara Tripic; Alexandra Rousseau; Stephen M Gottschalk; Barbara Savoldo; Juan F Vera; Helen E Heslop; Malcolm K Brenner; Catherine M Bollard; Cliona M Rooney; Ann M Leen
Journal:  Mol Ther       Date:  2011-09-13       Impact factor: 11.454

4.  Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes.

Authors:  J H Falkenburg; A R Wafelman; P Joosten; W M Smit; C A van Bergen; R Bongaerts; E Lurvink; M van der Hoorn; P Kluck; J E Landegent; H C Kluin-Nelemans; W E Fibbe; R Willemze
Journal:  Blood       Date:  1999-08-15       Impact factor: 22.113

5.  Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia.

Authors:  J J Molldrem; P P Lee; C Wang; K Felio; H M Kantarjian; R E Champlin; M M Davis
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

6.  Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.

Authors:  Aaron P Rapoport; Edward A Stadtmauer; Nicole Aqui; Ashraf Badros; Julio Cotte; Lisa Chrisley; Elizabeth Veloso; Zhaohui Zheng; Sandra Westphal; Rebecca Mair; Nina Chi; Bashi Ratterree; Mary Francis Pochran; Sabrina Natt; Joanne Hinkle; Cheryl Sickles; Ambika Sohal; Kathleen Ruehle; Christian Lynch; Lei Zhang; David L Porter; Selina Luger; Chuanfa Guo; Hong-Bin Fang; William Blackwelder; Kim Hankey; Dean Mann; Robert Edelman; Carl Frasch; Bruce L Levine; Alan Cross; Carl H June
Journal:  Nat Med       Date:  2005-10-16       Impact factor: 53.440

7.  Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia.

Authors:  W A Erik Marijt; Mirjam H M Heemskerk; Freke M Kloosterboer; Els Goulmy; Michel G D Kester; Menno A W G van der Hoorn; Simone A P van Luxemburg-Heys; Manja Hoogeboom; Tuna Mutis; Jan Wouter Drijfhout; Jon J van Rood; Roel Willemze; J H Frederik Falkenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

Review 8.  The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials.

Authors:  P Hwu; S A Rosenberg
Journal:  Cancer Detect Prev       Date:  1994

9.  Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.

Authors:  Yoshihiro Oka; Akihiro Tsuboi; Tetsuya Taguchi; Tadashi Osaki; Taiichi Kyo; Hiroko Nakajima; Olga A Elisseeva; Yusuke Oji; Manabu Kawakami; Kazuhiro Ikegame; Naoki Hosen; Satoshi Yoshihara; Fei Wu; Fumihiro Fujiki; Masaki Murakami; Tomoki Masuda; Sumiyuki Nishida; Toshiaki Shirakata; Shin-Ichi Nakatsuka; Ayako Sasaki; Keiko Udaka; Hiroo Dohy; Katsuyuki Aozasa; Shinzaburo Noguchi; Ichiro Kawase; Haruo Sugiyama
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

10.  Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.

Authors:  Katayoun Rezvani; Agnes S M Yong; Bipin N Savani; Stephan Mielke; Keyvan Keyvanfar; Emma Gostick; David A Price; Daniel C Douek; A John Barrett
Journal:  Blood       Date:  2007-05-15       Impact factor: 22.113
View more
  3 in total

1.  STAT3: the "Achilles" heel for AML?

Authors:  Katayoun Rezvani; John Barrett
Journal:  Blood       Date:  2014-01-02       Impact factor: 22.113

Review 2.  Current progress and future perspectives of polypharmacology : From the view of non-small cell lung cancer.

Authors:  Ramanathan Karuppasamy; Shanthi Veerappapillai; Sayoni Maiti; Woong-Hee Shin; Daisuke Kihara
Journal:  Semin Cancer Biol       Date:  2019-11-04       Impact factor: 17.012

Review 3.  Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches.

Authors:  Ji-Yoon Noh; Huiyun Seo; Jungwoon Lee; Haiyoung Jung
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.